Cargando…

A systematic review and meta-analysis of 235delC mutation of GJB2 gene

BACKGROUND: The 235delC mutation of GJB2 gene is considered as a risk factor for the non-syndromic hearing loss (NSHL), and a significant difference in the frequency and distribution of the 235delC mutation has been described world widely. METHODS: A systematic review was performed by means of a met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Jun, Lu, Yajie, Wei, Qinjun, Cao, Xin, Xing, Guangqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443034/ https://www.ncbi.nlm.nih.gov/pubmed/22747691 http://dx.doi.org/10.1186/1479-5876-10-136

Ejemplares similares

Hearing Phenotypes of Patients with Hearing Loss Homozygous for the GJB2 c.235delc Mutation
por: Guo, Chang, et al.
Publicado: (2020)

Phenotypic Heterogeneity of Post-lingual and/or Milder Hearing Loss for the Patients With the GJB2 c.235delC Homozygous Mutation
por: Wang, Hongyang, et al.
Publicado: (2021)

Genetic mutations of GJB2 and mitochondrial 12S rRNA in nonsyndromic hearing loss in Jiangsu Province of China
por: Wei, Qinjun, et al.
Publicado: (2013)

GJB2 c.235delC variant associated with autosomal recessive nonsyndromic hearing loss and auditory neuropathy spectrum disorder
por: Xia, Hong, et al.
Publicado: (2019)

A novel compound heterozygous mutation in the GJB2 gene causing non-syndromic hearing loss in a family
por: WEI, QINJUN, et al.
Publicado: (2014)

High Rates of Three Common GJB2 Mutations c.516G>C, c.-23+1G>A, c.235delC in Deaf Patients from Southern Siberia Are Due to the Founder Effect
por: Zytsar, Marina V., et al.
Publicado: (2020)

Identification of I411K, a novel missense EYA4 mutation causing autosomal dominant non-syndromic hearing loss
por: TAN, MINXING, et al.
Publicado: (2014)

CHEK2 (∗)1100delC Mutation and Risk of Prostate Cancer
por: Hale, Victoria, et al.
Publicado: (2014)

GPRASP2, a novel causative gene mutated in an X-linked recessive syndromic hearing loss
por: Xing, Guangqian, et al.
Publicado: (2017)

CHEK2 1100 delC mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2007)

Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
por: Massink, Maarten P. G., et al.
Publicado: (2015)

Probing the Effect of Two Heterozygous Mutations in Codon 723 of SLC26A4 on Deafness Phenotype Based on Molecular Dynamics Simulations
por: Yao, Jun, et al.
Publicado: (2015)

Mutations in OSBPL2 cause hearing loss associated with primary cilia defects via sonic hedgehog signaling
por: Shi, Hairong, et al.
Publicado: (2022)

The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis
por: Koppert, L B, et al.
Publicado: (2004)

Phenotypic Variability of c.436delC DCAF17 Gene Mutation in Woodhouse-Sakati Syndrome
por: Almeqdadi, Mohammad, et al.
Publicado: (2018)

A Case of Male Breast Cancer Patient with CHEK2*1100delC Mutation
por: Nguyen, Quan D, et al.
Publicado: (2020)

A Case of Severe Teratozoospermia and Infertility Due to Homozygous Mutation c.144delC in the AURKC Gene
por: Abbassi, Meriame, et al.
Publicado: (2023)

Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer risk
por: Varley, Jenny, et al.
Publicado: (2003)

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers
por: Kriege, Mieke, et al.
Publicado: (2015)

Targeted genomic capture and massively parallel sequencing to identify novel variants causing Chinese hereditary hearing loss
por: Wei, Qinjun, et al.
Publicado: (2014)

C.35delG/ GJB2 and del(GJB6-D13S1830) mutations in Croatians with prelingual non-syndromic hearing impairment
por: Medica, Igor, et al.
Publicado: (2005)

In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia
por: Lin, Shaoyi, et al.
Publicado: (2023)

Functional analysis of the novel TBX5 c.1333delC mutation resulting in an extended TBX5 protein
por: Böhm, Johann, et al.
Publicado: (2008)

Case Report: Pathogenic MYH9 c.5797delC Mutation in a Patient With Apparent Thrombocytopenia and Nephropathy
por: Ren, Pingping, et al.
Publicado: (2021)

CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
por: Isinger, Anna, et al.
Publicado: (2006)

Risk for contralateral breast cancer among carriers of the CHEK2(*)1100delC mutation in the WECARE Study
por: Mellemkjær, L, et al.
Publicado: (2008)

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
por: Muranen, Taru A, et al.
Publicado: (2011)

Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer
por: Ding, Dapeng, et al.
Publicado: (2012)

Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families
por: Cierniková, S, et al.
Publicado: (2005)

Molecular screening of patients with nonsyndromic hearing loss from Nanjing city of China()
por: Lu, Yajie, et al.
Publicado: (2011)

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
por: Hallamies, Sanna, et al.
Publicado: (2017)

A Homozygous RAB3GAP1:c.743delC Mutation in Rottweilers with Neuronal Vacuolation and Spinocerebellar Degeneration
por: Mhlanga‐Mutangadura, T., et al.
Publicado: (2016)

Genetic modifiers of CHEK2*1100delC associated breast cancer risk
por: Muranen, Taru A., et al.
Publicado: (2016)

Allele-Specific Impairment of GJB2 Expression by GJB6 Deletion del(GJB6-D13S1854)
por: Rodriguez-Paris, Juan, et al.
Publicado: (2011)

Deletion of OSBPL2 in auditory cells increases cholesterol biosynthesis and drives reactive oxygen species production by inhibiting AMPK activity
por: Wang, Hongshun, et al.
Publicado: (2019)

OSBPL2 Is Required for the Binding of COPB1 to ATGL and the Regulation of Lipid Droplet Lipolysis
por: Wang, Tianming, et al.
Publicado: (2020)

GJB2 and GJB6 Mutations in Non-Syndromic Childhood Hearing Impairment in Ghana
por: Adadey, Samuel M., et al.
Publicado: (2019)

CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer
por: Margolin, Sara, et al.
Publicado: (2007)

Frequency of CHEK2*1100delC in New York breast cancer cases and controls
por: Offit, Kenneth, et al.
Publicado: (2003)

The association between abnormal microRNA-10b expression and cancer risk: a meta-analysis
por: Lu, Yajie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_30s7j1dgkkbacdbqhj4nqqj5gh